MLSS — Milestone Scientific Share Price
- $77.60m
- $74.40m
- $8.63m
- 52
- 10
- 83
- 46
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 13.3 | ||
Price to Tang. Book | 13.65 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 8.99 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -78.87% | ||
Return on Equity | -68.09% | ||
Operating Margin | -55.32% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 5.44 | 10.3 | 8.81 | 9.83 | 8.63 | 10.93 | 13.13 | 0.6% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.
Directors
- Leslie Bernhard NEC (77)
- Jan Haverhals PRE (60)
- Leonard Osser VCH (73)
- Scott Kahn CFO
- Chet Trechock VPR
- Eugene Casagrande OTH (75)
- Mark Hochman OTH (60)
- Gian Trombetta DRC (60)
- Neal Goldman IND (77)
- Michael McGeehan IND (55)
- Leonard Schiller IND (79)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 17th, 1989
- Public Since
- November 3rd, 1995
- No. of Shareholders
- 3,488
- No. of Employees
- 17
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NYSE MKT
- Shares in Issue
- 78,379,633

- Address
- 220 S Orange Ave, LIVINGSTON, 07039-5804
- Web
- https://www.milestonescientific.com/
- Phone
- +1 9735352717
- Auditors
- Marcum LLP
Upcoming Events for MLSS
Milestone Scientific Inc Annual Shareholders Meeting
Q2 2025 Milestone Scientific Inc Earnings Release
Similar to MLSS
Acme United
NYSE MKT
Alpha Pro Tech
NYSE MKT
Catheter Precision
NYSE MKT
Electromed
NYSE MKT
Infusystem Holdings
NYSE MKT
FAQ
As of Today at 22:02 UTC, shares in Milestone Scientific are trading at $0.99. This share price information is delayed by 15 minutes.
Shares in Milestone Scientific last closed at $0.99 and the price had moved by +73.68% over the past 365 days. In terms of relative price strength the Milestone Scientific share price has outperformed the S&P500 Index by +60.32% over the past year.
The overall consensus recommendation for Milestone Scientific is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreMilestone Scientific does not currently pay a dividend.
Milestone Scientific does not currently pay a dividend.
Milestone Scientific does not currently pay a dividend.
To buy shares in Milestone Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.99, shares in Milestone Scientific had a market capitalisation of $77.60m.
Here are the trading details for Milestone Scientific:
- Country of listing: United States
- Exchange: ASQ
- Ticker Symbol: MLSS
Based on an overall assessment of its quality, value and momentum Milestone Scientific is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Milestone Scientific is $2.13. That is 115.15% above the last closing price of $0.99.
Analysts covering Milestone Scientific currently have a consensus Earnings Per Share (EPS) forecast of -$0.05 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Milestone Scientific. Over the past six months, its share price has outperformed the S&P500 Index by +33.78%.
As of the last closing price of $0.99, shares in Milestone Scientific were trading +3.5% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Milestone Scientific PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Milestone Scientific's management team is headed by:
- Leslie Bernhard - NEC
- Jan Haverhals - PRE
- Leonard Osser - VCH
- Scott Kahn - CFO
- Chet Trechock - VPR
- Eugene Casagrande - OTH
- Mark Hochman - OTH
- Gian Trombetta - DRC
- Neal Goldman - IND
- Michael McGeehan - IND
- Leonard Schiller - IND